Kiss Z, Deli E, Vogler W R, Kuo J F
Biochem Biophys Res Commun. 1987 Feb 13;142(3):661-6. doi: 10.1016/0006-291x(87)91465-3.
The tumor-promoting 12-0-tetradecanoylphorbol-13-acetate (TPA) stimulated phosphorylation of several proteins in block I (including protein Ia) and protein 3 in HL60 cells. The antileukemic agent alkyllysophospholipid (ALP) inhibited the TPA-stimulated phosphorylation of these proteins and the TPA-induced differentiation of the cells. In comparison, TPA only stimulated phosphorylation of protein 3 in K562 cells which, in contrast, were not induced to differentiate by TPA and lacked protein Ia and had a very high basal phosphorylation of protein B. ALP inhibited phosphorylation of protein 3 as well as protein B in K562 cells. The data suggest that the presence of distinct phosphoproteins and regulation of their phosphorylation may be related to the selective susceptibility of the two leukemia cell lines to the maturating effect of TPA and cytotoxicity of ALP.
促肿瘤的12 - 0 - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)刺激HL60细胞中I区的几种蛋白质(包括蛋白质Ia)和蛋白质3发生磷酸化。抗白血病药物烷基溶血磷脂(ALP)抑制TPA刺激的这些蛋白质的磷酸化以及TPA诱导的细胞分化。相比之下,TPA仅刺激K562细胞中蛋白质3的磷酸化,相反,K562细胞不会被TPA诱导分化,缺乏蛋白质Ia,并且蛋白质B的基础磷酸化水平非常高。ALP抑制K562细胞中蛋白质3以及蛋白质B的磷酸化。数据表明,不同磷蛋白的存在及其磷酸化调节可能与这两种白血病细胞系对TPA成熟作用和ALP细胞毒性的选择性敏感性有关。